Quality of life is an important consideration in cancer medicine, especially because drugs may only result in modest gains in overall survival. While almost all cancer trials require site visits, QoL data is best collected virtually. This can reduce the number of site visits required, which can strain an already burdened patient population. ObvioHealth’s app makes it easy for patients to submit e-diaries from the comforts of home. In addition, oncology studies almost always require close monitoring of patients to ensure safety. The inclusion of a virtual platform like ObvioGo™ allows for more consistent monitoring when patients are at home. This enables immediate detection of an adverse event so the study team and patient’s physicians can react appropriately for the patient’s health.
130 women were asked to consume an interventional product, update e-diaries daily, and complete digital questionnaires in weekly intervals, including reporting of hot flashes.
Read Full Case StudyOur proprietary application brings clinical research into people’s homes, making it easier for them to participate, and easier for researchers to collect robust data sets which reflect real behaviors.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor
Our e-diaries and validated questionnaires are specifically designed to be easy to use on a smartphone, using scales and pictograms so patients can always tell us how they’re feeling. Our virtual platform also includes device integration, allowing you to track a patient’s activity and sleep. Let us help you design a study that meets your endpoints while keeping patients engaged.
Our easy-to-use, convenient app increases our compliance & retention rates. We send push notifications to help remind participants to complete study activities. Our study team is always available to answer questions.
Our study team can monitor real-world data in real time. This allows for immediate AE detection and course correction.
• 93 % product compliance
• 56,286 data points evaluated in real time
ObvioHealth deployed a targeted digital recruitment strategy to enroll 128 patients with a blood pressure of 120-139/80-89 mmHg, living in the Houston and Atlanta areas. The study successfully achieved a diverse study population: 41% Caucasian, 39% African American, 20% "other race.”
Read Full Case StudyAssessing the efficacy of a medical device on pelvic floor dysfunction
Nearly a quarter of women in the United States have a pelvic floor disorder, according to the NIH. We’re in the midst of a clinical trial to evaluate a new treatment for these all-too-common pelvic-floor conditions.
Read Full Case Study